...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

RVXOT, so can we conclude that ZCC holds no IPs as things stand presently? And ZCC only holds the RVX royalty preferred shares.

If so does this mean that OTC ZHCLF shares represent ZCC and not Zenith Epigenetics?

 

Koo

Share
New Message
Please login to post a reply